January 6, 2025 · Form 4 insider transaction
Gallagher Kathleen P. bought 50,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This option vests in 48 equal installments on each monthly anniversary of the grant date, until it is fully vested on January 6, 2029.